Questions raised over accuracy of common IVF ‘screening’ test
A test widely used during in vitro fertilisation (IVF) to ‘screen out’ embryos deemed to have chromosomal conditions could be unreliable, a new study has revealed.
A test widely used during in vitro fertilisation (IVF) to ‘screen out’ embryos deemed to have chromosomal conditions could be unreliable, a new study has revealed.
The morning-after pill (MAP) is now available free of charge at pharmacies across England.